Purinergic Antagonist Suramin Aggravates Myocarditis and Increases Mortality by Enhancing Parasitism, Inflammation, and Reactive Tissue Damage in Trypanosoma cruzi-Infected Mice
Suramin (Sur) acts as an ecto-NTPDase inhibitor in Trypanosoma cruzi and a P2-purinoceptor antagonist in mammalian cells. Although the potent antitrypanosomal effect of Sur has been shown in vitro, limited evidence in vivo suggests that this drug can be dangerous to T. cruzi-infected hosts. Therefor...
Main Authors: | Rômulo D. Novaes, Eliziária C. Santos, Marli C. Cupertino, Daniel S. S. Bastos, Andréa A. S. Mendonça, Eduardo de Almeida Marques-da-Silva, Sílvia A. Cardoso, Juliana L. R. Fietto, Leandro L. Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2018/7385639 |
Similar Items
-
Purinergic Receptor Blockade with Suramin Increases Survival of Postnatal Neural Progenitor Cells In Vitro
by: Alejandro Herrera, et al.
Published: (2021-01-01) -
Rapamycin Treatment Reduces Acute Myocarditis Induced by Trypanosoma cruzi Infection
by: Thabata L.A. Duque, et al.
Published: (2019-12-01) -
Global metabolomic profiling of acute myocarditis caused by Trypanosoma cruzi infection.
by: Núria Gironès, et al.
Published: (2014-11-01) -
High fat diet modulates Trypanosoma cruzi infection associated myocarditis.
by: Fnu Nagajyothi, et al.
Published: (2014-10-01) -
Absence of Fas-L aggravates renal injury in acute Trypanosoma cruzi infection
by: Gabriel Melo de Oliveira, et al.
Published: (2009-12-01)